Gain insights into the U.S. market, valued at $363.4 Million in 2024, and China, forecasted to grow at an impressive 4.8% ...

Several trends are driving change in oral solid‑dosage forms and giving rise to the requirement of ‘fit-for-purpose’ excipients.